FIELD: biologically active substances, medicine.
SUBSTANCE: claimed agent for parantheral administration represents peptide complex containing 70-90 % of low molecular fraction comprising peptide components with molecular mass 70-184 Da, and peptide concentration of 2.5-2.9 mg/ml. Said agent is obtained from liver of calf not older than 12 months or hog by extraction with acetic acid in presence of zinc chloride. Calf or hog liver are frozen at not less -40°C, conditioned at -20-22°C for at least two months, and ground. Then 3 % acetic acid solution in volume ratio of 1:5 is added at 20±5°C. Extraction is carried out under continuous stirring to produce homogenous slurry. Then 1 % zinc chloride solution is added into slurry in volume ratio of 50:1; mixture is cooled under continuous stirring to 7-16°C; stirred during 1 h after each 4 h defecation for 48 hours. Extract is separated from ballast substances; acetone is added to extract in volume ratio of 1:5, followed by conditioning at 3-5°C for 4 hours. Obtained homogenized deposition is deposited again with acetone two time or more. Further active substance containing precipitate is washed on gravity filter with two-fold volumes of acetone cooled to 7-16°C to produce light-gray precipitate. Precipitate is passed through metal sieve, dried, dissolved in distilled water at room temperature and continuous stirring to produce polypeptide concentration of 2.5-2.9 mg/ml. Solution is centrifuged, filtered, subjected to ultrafiltration purification under back pressure of 1.0 kgf/cm2 or less trough materials with retentiveness of 15000 Da. Glycocol is added into ultrafiltrate up to finish concentration of 10-20 mg/mg at pH 5.6-6.6. Solution is subjected to sterilizing filtration under pressure of 2.0 kgf/cm2 or less, poured in 2 ml ampoules, and autoclaved for 8 min, at 120°C and atmospheric pressure of 1.1 kgf/cm2.
EFFECT: method of increased yield, non-toxic and apirogenic agent of improved purity.
2 cl, 5 ex, 4 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
AGENT NORMALIZING KIDNEY FUNCTION AND METHOD FOR ITS PREPARING | 2006 |
|
RU2302868C1 |
AGENT NORMALIZING REPRODUCTIVE FUNCTION IN MEN AND METHOD FOR ITS PREPARING | 2006 |
|
RU2302874C1 |
AGENT NORMALIZING PANCREAS FUNCTION AND METHOD FOR ITS PREPARING | 2006 |
|
RU2302875C1 |
AGENT NORMALIZING CARTILAGE TISSUE FUNCTION AND METHOD FOR ITS PREPARING | 2006 |
|
RU2302872C9 |
PREPARATION FOR NORMALIZING FEMALE REPRODUCTIVE FUNCTION AND METHOD FOR ITS OBTAINING | 2006 |
|
RU2303454C1 |
AGENT FOR NORMALIZING OF BLOOD-VESSEL FUNCTION AND METHOD FOR PRODUCTION THEREOF | 2006 |
|
RU2301072C1 |
BRAIN FUNCTIONS NORMALIZING AGENT AND A METHOD FOR PREPARATION THEREOF | 2006 |
|
RU2302871C1 |
AGENT NORMALIZING BLADDER TONUS AND METHOD FOR ITS PREPARING | 2006 |
|
RU2302867C1 |
GEROPROTECTOR ACTIVITY EXHIBITING AGENT AND A METHOD FOR PREPARATION THEREOF | 2006 |
|
RU2302870C1 |
TETRAPEPTIDE STIMULATING FUNCTIONAL ACTIVITY OF HEPATOCYTES, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD OF ITS USE | 2000 |
|
RU2166957C1 |
Authors
Dates
2007-06-20—Published
2006-06-22—Filed